The Enzen Trial: Analysis of EVAR Endoprosthesis Zenith and Endurant for Infrarenal Aortoiliac Aneurysms Regarding Outcomes, Endoleaks, and Reinterventions.
Raphael de Athayde SoaresMatheus Veras Viana PortelaKaline AmaroAna Izabel NasserKeityane de Lima PedrosaRoberto SacilottoPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2024)
In this present study, Zenith endograft had higher rates of endoleaks, aneurysms related mortality, limb graft occlusions and reinterventions than patients submitted to Endurant II endografts. The main impact and the innovation that this article provides is an opportunity to evaluate and choose the best endograft suitable for the patient with AAA during EVAR.